In this Issue:
Retinal microvessels and familial vulnerability to psychotic symptoms
Brexpiprazole for the treatment of acute schizophrenia
A histamine H3 receptor antagonist for cognitive impairment in schizophrenia
Sustained blockade of dopamine D2 receptor in the maintenance treatment of schizophrenia
Culturally adapted CBT for psychosis
Prefrontal cortical and extrastriatal dopamine release in schizophrenia
Social functioning in young first-episode psychosis patients with cannabis misuse
Autistic traits in patients with mood disorders and schizophrenia
Paliperidone palmitate vs oral antipsychotic therapy in schizophrenia
Analysis of psychiatrist recommendations for injectable therapy to patients with schizophrenia
Please login below to download this issue (PDF)